Clinical Trial

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To enhance the treatment efficacy of rectal cancer liver metastasis through a multidisciplinary approach of radiotherapy, immunotherapy, and chemotherapy, and to provide a new direction for the combination treatment strategy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-16; most recent amendment 2026-02-28.
Status change: Not Yet Recruiting → Recruiting 2026-02-28
Trial Details
NCT Number NCT06787183
Lead Sponsor Fujian Cancer Hospital
Conditions Locally Advanced Rectal Cancer With Liver Metastases
Enrollment 42 participants
Start Date 2025-12-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-03